Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Huntington's disease

Not recruiting

Investigational

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Investigational

Germany

Participants:18–64 years
Substances:Tominersen

Contact Research Centre

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Germany

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Corneal dystrophy

Not recruiting

Investigational

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ripasudil

Contact Research Centre

Chronic myeloid leukaemia+2

Not recruiting

Registered drugNo placebo

Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Asciminib

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drugNo placebo

Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Alopecia areata

Not recruiting

InvestigationalNo placebo

Long-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Neuroendocrine tumour+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Octreotide

Contact Research Centre

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Find therapies in clinical trials near you – page 27

388 trials match your criteria

Huntington's disease

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Corneal dystrophy

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

Chronic myeloid leukaemia+2

Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

Breast cancer+3

Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Alopecia areata

Long-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata

Neuroendocrine tumour+1

Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Hidradenitis

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Systemic lupus erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Chronic myeloid leukaemia

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.